Increased affinity of dopamine for D 2-like versus D 1-like receptors. Relevance for volume transmission in interpreting PET findings

Synapse

Volumn 66, Issue 3, 2012, Pages 196-203

  Marcellino, Daniel ^a   Kehr, Jan ^a   Agnati, Luigi F ^b   Fuxe, Kjell ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

D 1 receptors; D 2 receptors; Dopamine; Receptor affinity; Volume transmission

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE H 3; AMPHETAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; RACLOPRIDE; RACLOPRIDE H 3; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BRAIN MEMBRANE; CELL MEMBRANE; CHO CELL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; IC 50; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR BINDING;

ANIMALS; BENZAZEPINES; CHO CELLS; CORPUS STRIATUM; CRICETINAE; CRICETULUS; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINERGIC NEURONS; MALE; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 84855270073     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21501     Document Type: Article

References (52)

1. Agnati LF, Fuxe K, Zoli M, Ozini I, Toffano G, Ferraguti F. 1986. A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: The volume transmission and the wiring transmission. Acta Physiol Scand 128: 201-207.
2. Auclair A, Blanc G, Glowinski J, Tassin JP. 2004. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: Comparison with previous data on alpha1b-adrenergic receptors. J Neurochem 91: 318-326.
3. Bergson C, Mrzljak L, Smiley JF, Pappy M, Levenson R, Goldman-Rakic PS. 1995. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci 15: 7821-7836.
4. Caille I, Dumartin B, Bloch B. 1996. Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation. Brain Res 730: 17-31.
5. Chou YH, Karlsson P, Halldin C, Olsson H, Farde L. 1999. A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain. Psychopharmacology (Berl) 146: 220-227.
6. Cragg SJ, Rice ME. 2004. DAncing past the DAT at a DA synapse. Trends Neurosci 27: 270-277.
7. Dana C, Vial M, Leonard K, Beauregard A, Kitabgi P, Vincent JP, Rostene W, Beaudet A. 1989. Electron microscopic localization of neurotensin binding sites in the midbrain tegmentum of the rat. I. Ventral tegmental area and the interfascicular nucleus. J Neurosci 9: 2247-2257.
8. Descarries L, Mechawar N. 2000. Ultrastructural evidence for diffuse transmission by monoamine and acetylcholine neurons of the central nervous system. Prog Brain Res 125: 27-47.
9. Descarries L, Watkins KC, Garcia S, Bosler O, Doucet G. 1996. Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: A quantitative autoradiographic and immunocytochemical analysis. J Comp Neurol 375: 167-186.
10. Dewey SL, Smith GS, Logan J, Brodie JD, Fowler JS, Wolf AP. 1993. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13: 350-356.
11. Dumartin B, Caille I, Gonon F, Bloch B. 1998. Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists. J Neurosci 18: 1650-1661.
12. Fuxe K, Agnati LF, editors. 1991a. Volume transmission in the brain. New York: Raven Press. 602 p.
13. Fuxe K, Agnati LF. 1991b. Two principle modes of electrochemical communication in the brain: Volume versus wiring transmission. In: Fuxe K, Agnati LF, editors. Volume transmission in the brain: Novel mechanisms of neuronal transmission. New York: Raven Press. pp 1-9.
14. Fuxe K, Ungerstedt U. 1970. Histochemical, biochemical and functional studies on central monoamine neurons after chronic amphetamine administration. In: Costa E, Garattini S, editors. Amphetamines and related compounds. New York: Raven Press. pp 257-288.
15. Fuxe K, Andersson K, Harfstrand A, Agnati LF. 1986. Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smoke. J Neural Transm 67: 15-29.
16. Fuxe K, Agnati LF, Cintra A, Andersson K, Eneroth P, Harfstrand A, Zoli M, Goldstein M. 1988a. Studies on central D1 receptors role in volume transmission, neuroendrocrine regulation and release of noradrenaline. Adv Exp Med Biol 235: 83-119.
17. Fuxe K, Cintra A, Agnati LF, Harfstrand A, Goldstein M. 1988b. Studies on the relationship of tyrosine hydroxylase, dopamine and cyclic amp-regulated phosphoprotein-32 immunoreactive neuronal structures and d1 receptor antagonist binding sites in various brain regions of the male rat-mismatches indicate a role of d1 receptors in volume transmission. Neurochem Int 13: 179-197.
18. Fuxe K, Dahlstrom A, Hoistad M, Marcellino D, Jansson A, Rivera A, Diaz-Cabiale Z, Jacobsen K, Tinner-Staines B, Hagman B, Leo G, Staines W, Guidolin D, Kehr J, Genedani S, Belluardo N, Agnati LF. 2007. From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission. Brain Res Rev 55: 17-54.
19. Fuxe K, Dahlstrom AB, Jonsson G, Marcellino D, Guescini M, Dam M, Manger P, Agnati L. 2010. The discovery of central monoamine neurons gave volume transmission to the wired brain. Prog Neurobiol 90: 82-100.
20. Grenhoff J, Aston-Jones G, Svensson TH. 1986. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128: 351-358.
21. Hersch SM, Ciliax BJ, Gutekunst CA, Rees HD, Heilman CJ, Yung KK, Bolam JP, Ince E, Yi H, Levey AI. 1995. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15: 5222-5237.
22. Ito K, Haga T, Lameh J, Sadee W. 1999. Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem 260: 112-119.
23. Iwata K, Ito K, Fukuzaki A, Inaki K, Haga T. 1999. Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors. Eur J Biochem 263: 596-602.
24. Jansson A, Goldstein M, Tinner B, Zoli M, Meador-Woodruff JH, Lew JY, Levey AI, Watson S, Agnati LF, Fuxe K. 1999. On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat. Neuroscience 89: 473-489.
25. Jansson A, Descarries L, Cornea-Hebert V, Riad M, Verge D, Bancila M, Agnati LF, Fuxe K. 2002. Transmitter-receptor mismatches in central dopamine seratonin and neuropeptide systems. In: Walz W, editor. The neuronal environment; environment: Brain homeostasis in health and disease. Totowa, NJ: Humana Press. pp 83-107.
26. Justice JB Jr. 1993. Quantitative microdialysis of neurotransmitters. J Neurosci Methods 48: 263-276.
27. Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, Yoshitake T. 2011. Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats. Br J Pharmacol. doi:10.1111/j.1476-5381.2011.01499.x. [Epub ahead of print].
28. Kim SE, Han SM. 2009. Nicotine- and methamphetamine-induced dopamine release evaluated with in-vivo binding of radiolabelled raclopride to dopamine D2 receptors: Comparison with in-vivo microdialysis data. Int J Neuropsychopharmacol 12: 833-841.
29. Kim SE, Shim I, Oh SJ, Kim SH, Choe YS, Choi Y, Kim BT. 1998. Nicotine-induced dopamine release evaluated with in vivo H-3 raclopride binding studies: Comparison with in vivo microdialysis data. J Nucl Med 39: 54 p.
30. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 20: 423-451.
31. Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lanca AJ, O'Dowd BF, George SR. 2004. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279: 35671-35678.
32. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ. 1993. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci U S A 90: 8861-8865.
33. Madras BK, Fahey MA, Canfield DR, Spealman RD. 1988. D1 and D2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis). J Neurochem 51: 934-943.
34. Marcellino D, Ferre S, Casado V, Cortes A, Le Foll B, Mazzola C, Drago F, Saur O, Stark H, Soriano A, Barnes C, Goldberg SR, Lluis C, Fuxe K, Franco R. 2008. Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem 283: 26016-26025.
35. Martin-Negrier ML, Charron G, Bloch B. 2006. Receptor recycling mediates plasma membrane recovery of dopamine D1 receptors in dendrites and axons after agonist-induced endocytosis in primary cultures of striatal neurons. Synapse 60: 194-204.
36. Mukherjee J, Yang ZY, Lew R, Brown T, Kronmal S, Cooper MD, Seiden LS. 1997. Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, 18F-fallypride in nonhuman primates using positron emission tomography. Synapse 27: 1-13.
37. Neve KA, Neve RL. 1997. Molecular biology of dopamine receptors. In: Neve KA, Neve RL, editors. The dopmaine receptors. Totowa, NJ: Humana Press, pp 27-76.
38. Ng GY, Trogadis J, Stevens J, Bouvier M, O'Dowd BF, George SR. 1995. Agonist-induced desensitization of dopamine D1 receptor-stimulated adenylyl cyclase activity is temporally and biochemically separated from D1 receptor internalization. Proc Natl Acad Sci U S A 92: 10157-10161.
39. Paspalas CD, Rakic P, Goldman-Rakic PS. 2006. Internalization of D2 dopamine receptors is clathrin-dependent and select to dendro-axonic appositions in primate prefrontal cortex. Eur J Neurosci 24: 1395-1403.
40. Perreault ML, Hasbi A, Alijaniaram M, Fan T, Varghese G, Fletcher PJ, Seeman P, O'Dowd BF, George SR. 2010. The dopamine D1-D2 receptor heteromer localize in dynorphin/encephalin neurons: Increased high affinity state follow-ing amphetamine and in schizophrenia. J Biol Chem 285: 36625-36634.
41. Rice ME, Cragg SJ. 2008. Dopamine spillover after quantal release: Rethinking dopamine transmission in the nigrostriatal pathway. Brain Res Rev 58: 303-313.
42. Schoffelmeer AN, Hogenboom F, Mulder AH, Ronken E, Stoof JC, Drukarch B. 1994. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: Possible implications for the regulatory role of D2 receptors. Synapse 17: 190-195.
43. Seeman P, Van Tol HH. 1994. Dopamine receptor pharmacology. Trends Pharmacol Sci 15: 264-270.
44. Seneca N, Finnema SJ, Farde L, Gulyas B, Wikstrom HV, Halldin C, Innis RB. 2006. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: A comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride. Synapse 59: 260-269.
45. Sesack SR, Aoki C, Pickel VM. 1994. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14: 88-106.
46. Smiley JF, Levey AI, Ciliax BJ, Goldman-Rakic PS. 1994. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: Predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci U S A 91: 5720-5724.
47. Tirotta E, De Mei C, Iitaka C, Ramos M, Holmes D, Borrelli E. 2010. Unraveling the role of dopamine receptors in vivo: Lessons from knockout mice. In: Neve KA, editor. The dopamine receptors. New York: Humana Press, pp 303-322.
48. Torvinen M, Kozell LB, Neve KA, Agnati LF, Fuxe K. 2004. Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor. J Mol Neurosci 24: 173-180.
49. Tsukada H, Miyasato K, Kakiuchi T, Nishiyama S, Harada N, Domino EF. 2002. Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys. Synapse 45: 207-212.
50. Vilardaga JP, Agnati LF, Fuxe K, Ciruela F. 2010. G-protein-coupled receptor heteromer dynamics. J Cell Sci 123: 4215-4220.
51. Yung KK, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI. 1995. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy. Neuroscience 65: 709-730.
52. Zoli M, Agnati LF. 1996. Wiring and volume transmission in the central nervous system: The concept of closed and open synapses. Prog Neurobiol 49: 363-380.